Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Stella

Recruiting

Back to Atypical Hemolytic-Uremic Syndrome trials

Trial locations(141 sites)

United States

Clinical Trial Site, Aurora, Colorado

Clinical Trial Site, Washington D.C., District of Columbia

Clinical Trial Site, Gainesville, Florida

Clinical Trial Site, Atlanta, Georgia

Clinical Trial Site, Chicago, Illinois

Key details

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators

Syneos Health

Enrollment target

~3,000 participants

Started

March 2013

Primary completion

January 2031

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov